Cisplatin 2

DRUG3 trials

Sponsors

Sun Yat-sen University

Conditions

Nasopharyngeal Carcinoma

Phase 2

Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2016-01-31End: 2022-01-31Target: 130Updated: 2016-05-26

Phase 3

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2016-01-31End: 2024-01-31Target: 534Updated: 2015-12-04

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2016-08-31End: 2021-08-31Target: 235Updated: 2016-06-01